Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 4 months ago
Share
A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
150 patients around the world
Available in
United States, Brazil, Spain
Biogen
1
Research sites
150
Patients around the world
This study is for people with
Motor neuron disease
Amyotrophic lateral sclerosis/als
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital São Paulo
Recruiting
View site
Rua Pedro de Toledo, 910-960 - Vila Clementino, São Paulo - SP, 04039-002
Hospital São Paulo
Recruiting
View site
Rua Pedro de Toledo, 910-960 - Vila Clementino, São Paulo - SP, 04039-002
See details
Contact us
Contact us
Study
ATLAS
Sponsor
Biogen
Study type
Interventional
Conditions
Amyotrophic lateral sclerosis/als
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT04856982
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent